Download document

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
P73
Shatil Amin
March 27th 2003
..Content
I. Structure and Function
II. Regulation
III. Is it involved in human cancers?
Early Findings
• Related to p53 tumor suppressor family
• Activated by DNA damage
• Mediates GI/S cell cycle arrest and apoptosis
• p73 is a transcription factor
– Target genes: BAX  apoptosis
WAF1(p21)  Cell cycle arrest
DNA damage
p73
Growth Arrest
Apoptosis
TARGET GENES
P21
BAX
TP73 gene  many different
mRnas
• TP73 gene produces 2 classes of isoforms:
– TAp73 isoform (transcriptionally active ,
apoptotic/growth inhibitory activity)
– ∆Np73 isoform
• ∆Np73 isoform lacks transcriptional activity
– Amino truncated
– Controlled by alternate promoter in the same
gene
Promoter 1  TAp73 isoforms (transcriptionally active…antiapoptotic
and growth inhibitory activity)
Promoter 2  Np73 isoforms (NO transcriptional activity)
TP73 gene
One gene, but two different proteins under the control of two
distinct promoters
∆Np73 isoform is a dominant
negative regulator of p53/TAp73
• Inhibits p53 and p73
– Competition for binding
– Oligimerization
• Oncogenic properties !!
• p53 and TAp73 activate Np73
 Dominant negative feedback loop
How does
NAp73 inhibit
p53 and TAp73?
-Oligimerization
-Competition for binding
sites
Tight regulation via
dominant negative
feedback loop!
**One gene: 2 products that are functionally antagonistic**
Involvement in Cancer?
• Ip36 locus commonly deleted in tumors
– Is p73 a tumor suppressor ?
• Tp73 mutations rare in human primary tumors
– Fewer than .5%
• Tp73 knockout mice don’t produce tumors
So…this evidence suggests it’s not a classical tumor
suppressor
Complications in assessing the
role of p73 in tumorigenesis
• Tp73 encodes two functionally opposing proteins:
– An in vitro tumor suppressor (TAp73) and a putative
oncogene (∆Np73)
• Mutations may affect both TAp73 and ∆Np73
together
– Deletions
• Abrogate both in vitro growth inhibitory and
oncogenic activity…..(no net effect!)
• Need to discriminate between TAp73 and ∆Np73
isoforms !!
Experiments that Discriminate
between TAp73 and ∆Np73
Variants of ∆Np73 (with anti-apoptotic activity)
overexpressed in breast cancer cell lines, ovarian
cancer, vulval cancer, and neuroblastic tumors
Used RTPCR
Np73
isoform
Ng SW et.al
• ∆Np73 expression strong adverse prognostic
indicator in Neuroblastoma
– No Np73 expression = 80% survival
– Overexpress Np73 = none survived
• ∆Np73 function (blocking p53 and TAp73
mediated apoptosis) is key to development of
tumor
• Mutation/inactivation of entire gene does not
necessarily lead to cancer
• TA:∆N ratio is what may be altered in cancer !
– Regulating respective promoters (mythylation)
Review of Main Points
• Tp73 gene: two functionally different proteins
– TAp73: stimulates apoptosis and cell cycle arrest in
response to DNA damage
– ∆Nap73: negative regulator of p53 and TAp73 with
oncogenic properties
• Enhanced expression of Np73 form associated
with cancer
• Future Research: assessing TA:Np73 ratios in
cancer